Definitive Contract 75N95026C00003
- Not listed
- The Department of Justice Drug Enforcement Administration awarded a Firm Fixed Price purchase order contract to The McLean Hospital Corporation, a non-profit hospital and research organization, to provide study reports and results from a scientific investigation. The contract has a potential value of $126,418.62 and a completion date of January 5, 2022. The original solicitation was a pre-solicitation notice, posted on April 1, 2020, with a due date of June 4, 2020. The contract is not set aside...
- This federal contract was awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to the University of Miami to establish a collection site (the NIH Brain and Tissue Repository) that will actively acquire, receive, store, curate, preserve, and distribute central nervous system and related biological specimens for research on neurological, psychiatric, and neurodevelopmental disorders. The $25,542,514.53 contract is for a definitive, cost-no-fee...
- This is a federal contract award to The Mclean Hospital Corporation, a non-profit psychiatric teaching hospital affiliated with Harvard Medical School. The contract, awarded by the Drug Enforcement Administration (DEA), is a Blanket Purchase Agreement (BPA) with a ceiling value of $1,062,961.53 over five years. The BPA enables the DEA to access Mclean Hospital's expertise in monitoring and regulating controlled substances, regulated chemicals, and emerging drugs. This contract is not...
- This federal contract award, valued at $2,692,445.32, was granted by the National Institute on Drug Abuse (NIDA) to The Mclean Hospital Corporation, a non-profit psychiatric teaching hospital affiliated with Harvard Medical School. The contract, which has a period of performance ending on December 15, 2025, is for the "Assessment of Potential Substance Abuse Treatment Medications in Nonhuman Primate Models." The original solicitation was a sources sought notice to identify qualified...
- This is a five-year, $6,249,115.20 definitive contract awarded by the National Institute on Drug Abuse (NIDA) to The McLean Hospital Corporation, a non-profit psychiatric teaching hospital affiliated with Harvard Medical School. The contract is for the "Assessment of Potential Substance Abuse Treatment Medications in Nonhuman Primate Models." The original solicitation was a small business sources sought notice to obtain capability statements from small businesses for this work....
- This is a $15,570,163.30 definitive contract awarded by the National Institute on Drug Abuse (part of the National Institutes of Health) to the Icahn School of Medicine at Mount Sinai (ISMMS) to establish a collection site for the NIH Brain and Tissue Repository (NBTR). The purpose is to acquire, receive, process, store, curate, preserve, and distribute central nervous system and related biological samples to support research on neurological, psychiatric, and neurodevelopmental disorders. The...
- This is a federal contract award from the National Institute on Drug Abuse (NIDA), a civilian agency within the National Institutes of Health (NIH), to the Greater Los Angeles Veterans Research And Education Foundation (GLAVREF), a non-profit organization. The contract, valued at $12,774,018.84, is for the NIH NEUROBIOBANK BRAIN AND TISSUE REPOSITORY and has a period of performance from September 1, 2019 to August 31, 2020, with a potential ultimate completion date of October 31, 2025. The...
- This $357,389 firm fixed price purchase order contract was awarded by the National Institute of Mental Health (NIMH), a civilian agency within the U.S. Department of Health and Human Services, to the Commonwealth of Virginia State Board of Health's Office of Epidemiology division. The contract is for the provision of donor human brain specimens and related peripheral services to support NIMH's Human Brain Collection Core, which conducts research into neurological and psychiatric disorders....
- The National Institute of Mental Health (NIMH) awarded a $594,011.14 firm fixed price purchase order contract to the Virginia Department of Health's Office of the Chief Medical Examiner (OCME) to provide postmortem human brain and tissue specimens to support the NIMH's Human Brain Collection Core (HBCC) and ongoing research into neurological and psychiatric disorders. The contract is not set aside and runs through September 29, 2027. The OCME, a state government entity, has demonstrated...
- <p>This is a $1,433,356.00 firm fixed price definitive contract awarded by the National Institute on Drug Abuse, a civilian federal agency, to The Brain Donor Project, a non-profit organization located in Naples, Florida. The contract is for NEUROBIOBANK (NBB) communications and outreach services from September 30, 2022 to September 29, 2026, with a potential completion date of September 29, 2027. The contract does not have a set-aside designation.</p>
The National Institute on Drug Abuse awarded a definitive cost-no-fee contract valued at approximately $34.5 million to The McLean Hospital Corporation to establish and operate the NIH NeuroBank Brain and Tissue Repository collection site in Belmont, Massachusetts. Under this five-year contract extending through October 31, 2030, McLean Hospital will actively acquire, receive, process, store, curate, preserve, and distribute central nervous system (CNS) and related tissues for neurological, psychiatric, and neurodevelopmental disorder research. This no-set-aside contract is part of a larger multi-agency initiative coordinated by the National Institute of Mental Health, National Institute of Child Health and Human Development, National Institute of Neurological Diseases and Stroke, and the National Institute on Aging to expand the availability of post-mortem human brain tissue from diverse donor populations for federally supported research. As a Harvard Medical School-affiliated non-profit psychiatric teaching hospital with extensive neuroscience and mental health research capabilities, McLean Hospital is positioned to meet the solicitation's requirement to acquire a minimum of 70 donors annually, with capacity for up to 150 unique human donors per year. The contractor must ensure demographic diversity across race, ethnicity, and age groups, including donors with various neurodevelopmental, neurological, and neuropsychiatric disorders as well as controls without known brain disorders. All acquired tissue inventory will be documented and maintained through the NIH NeuroBank Portal and distributed to researchers in compliance with NIH NeuroBank guidelines, supporting the government's objective to facilitate research across multiple neurological and psychiatric conditions.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
NIH NeuroBioBank Brain and Tissue Repository | 75N95024R00124 | Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse | Solicitation 2/2 | 10/15/24, 3:08 PM | |
NIH NeuroBioBank Brain and Tissue Repository | 75N95024R00124 | Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse | Pre-Solicitation 1/2 | 9/30/24, 2:52 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 10/28/25 |